Natera Company
Natera is a global leader in providing cell-free DNA testing across multiple clinical areas including women's health, organ health, and oncology. Natera offers a full menu of high-quality genetic tests to support the entire spectrum of women’s health needs—from planning a family and prenatal testing to hereditary cancer screening. Natera has implemented the Panorama AI algorithm, which uses advanced probabilistic modeling and AI-based technology, information from more than 2 million DNA tests performed by Natera.
Investors
Connections from
Founded Date:
2004
Total Funding:
809150000
Employee Number:
1001-5000
Funding Status:
IPO
Technology:
Pregnancy biomarkers, Biomarkers of Female Cancers
Last Funding Type:
Post-IPO Equity
Investors Number:
15
Last Funding Date:
2022-11-15
Industry:
Women's Longevity
Headquarters:
San Carlos, California, United States
Estimated Revenue:
$500M to $1B